Syncona Investment Management Limited (“SIML”), a leading life science investment manager, today highlights how its company-creation model is translating frontier science into breakthrough medicines by building ambitious, scalable and commercially attractive …
Synconas maturing portfolio entering a period of significant clinical and strategic milestones, positioning the business for near-term value creation and enabling returns to shareholders
